The Goldman Sachs Group has entered into an agreement to acquire Industry Ventures, a leading venture capital platform that invests in businesses and funds across all stages of the venture capital ...

Funding through the third quarter surpassed last year’s total, according to PitchBook. Meanwhile, average deal sizes are ...

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Two Silicon Valley venture capitalists are creating a new venture capital ...

In its 53-year history, Sofinnova Partners has invested in more than 500 companies. The venture capital firm now has €1.2 billion to invest in more. The additional funds have come at a fast clip.

Like other growth industries, many of its boosters stand to get rich. More than others, though, life sciences champions credibly claim their businesses can save lives. Even better to thrill local flag ...

On the heels of a $3 billion fund from Bain Capital Life Sciences, Arch Venture Partners is proving it can go toe-to-toe with the other investor, closing a VC fund of "more than $3 billion." The ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

This week on StrictlyVC Download, TechCrunch Editor-in-Chief Connie Loizos talks with Uncork Capital’s Jeff Clavier and Andy McLoughlin. They discuss how their seed-stage firm is positioning itself in ...

As a valuation reset for what investors might describe as overvalued tech companies came to fruition in the third quarter, the largest venture capital law firms witnessed deal work fall, with several ...

The life sciences industry is fueled by innovation, knowledge and insight. Thriving companies within this industry, whether biotechnology, pharmaceuticals, medical devices, diagnostics or research ...